MDPI and ACS Style
Puente-Iglesias, M.; Cuartero-MartÃnez, A.; Touriño-Peralba, R.; RodrÃguez-Ares, M.T.; Giráldez, M.J.; Yebra-Pimentel, E.; GarcÃa-Quintanilla, L.; GarcÃa-Otero, X.; González-Barcia, M.; Zarra-Ferro, I.;
et al. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study. Int. J. Mol. Sci. 2024, 25, 9847.
https://doi.org/10.3390/ijms25189847
AMA Style
Puente-Iglesias M, Cuartero-MartÃnez A, Touriño-Peralba R, RodrÃguez-Ares MT, Giráldez MJ, Yebra-Pimentel E, GarcÃa-Quintanilla L, GarcÃa-Otero X, González-Barcia M, Zarra-Ferro I,
et al. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study. International Journal of Molecular Sciences. 2024; 25(18):9847.
https://doi.org/10.3390/ijms25189847
Chicago/Turabian Style
Puente-Iglesias, MarÃa, Andrea Cuartero-MartÃnez, Rosario Touriño-Peralba, MarÃa Teresa RodrÃguez-Ares, MarÃa Jesús Giráldez, Eva Yebra-Pimentel, Laura GarcÃa-Quintanilla, Xurxo GarcÃa-Otero, Miguel González-Barcia, Irene Zarra-Ferro,
and et al. 2024. "Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study" International Journal of Molecular Sciences 25, no. 18: 9847.
https://doi.org/10.3390/ijms25189847
